These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy with thallium scintigraphy to improve viability detection. Sicari R; Varga A; Picano E; Borges AC; Gimelli A; Marzullo P Am J Cardiol; 1999 Jan; 83(1):6-10. PubMed ID: 10073776 [TBL] [Abstract][Full Text] [Related]
3. Dipyridamole-thallium versus dobutamine echocardiographic stress testing: a clinician's viewpoint. Johns JP; Abraham SA; Eagle KA Am Heart J; 1995 Aug; 130(2):373-85. PubMed ID: 7631623 [No Abstract] [Full Text] [Related]
5. Whole-body imaging of thallium-201 after six different stress regimens. Pennell DJ; Ell PJ J Nucl Med; 1994 Mar; 35(3):425-8. PubMed ID: 8113888 [TBL] [Abstract][Full Text] [Related]
6. Dipyridamole thallium-201 imaging versus dobutamine echocardiography for the evaluation of coronary artery disease in patients unable to exercise. Simek CL; Watson DD; Smith WH; Vinson E; Kaul S Am J Cardiol; 1993 Dec; 72(17):1257-62. PubMed ID: 8256700 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Gould KL Am J Cardiol; 1978 Feb; 41(2):267-78. PubMed ID: 623018 [No Abstract] [Full Text] [Related]
9. Diagnosing coronary heart disease: when to use stress imaging studies. Hayes SN; McBride P J Fam Pract; 2003 Jul; 52(7):544-51. PubMed ID: 12841971 [No Abstract] [Full Text] [Related]
10. Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise. Lee J; Chae SC; Lee K; Heo J; Iskandrian AS J Nucl Med; 1994 Apr; 35(4):535-41. PubMed ID: 8151371 [TBL] [Abstract][Full Text] [Related]
11. Effects of dipyridamole on coronary collateralization and myocardial perfusion in patients with ischaemic cardiomyopathy. Belardinelli R; Belardinelli L; Shryock JC Eur Heart J; 2001 Jul; 22(14):1205-13. PubMed ID: 11440493 [TBL] [Abstract][Full Text] [Related]
12. Are the differences between adenosine and dipyridamole clinically relevant? Iskandrian AS J Nucl Cardiol; 1996; 3(3):281-3. PubMed ID: 8805748 [No Abstract] [Full Text] [Related]
17. Comparison of 201Tl scintigraphy and low-dose dobutamine echocardiography for the noninvasive assessment of myocardial viability. Beller GA Circulation; 1996 Dec; 94(11):2681-4. PubMed ID: 8941086 [No Abstract] [Full Text] [Related]
18. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. II. Clinical methodology and feasibility. Gould KL; Westcott RJ; Albro PC; Hamilton GW Am J Cardiol; 1978 Feb; 41(2):279-87. PubMed ID: 623019 [No Abstract] [Full Text] [Related]
19. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina]. Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038 [TBL] [Abstract][Full Text] [Related]
20. Different tracers and stressors in patients with coronary artery disease: how to standardize clinical questions and nuclear cardiology answers. Marzullo P; Sambuceti G; Gimelli A; Giorgetti A; Parodi O J Nucl Biol Med (1991); 1994 Dec; 38(4):566-72. PubMed ID: 7786918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]